Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone
It is sold for research use only
As always, consider your individual needs and speak with a healthcare professional before starting a new supplement.
Theres no definitive link between such peptides and tumor growth
Tesamorelin: The FDA-Approved Benchmark What sets tesamorelin apart Tesamorelin holds a unique position in the GH peptide landscape: it is the only GHRH analogue to receive FDA approval, granted in 2010 under the brand name Egrifta for the treatment of excess abdominal fat in HIV-infected adults with lipodystrophy a metabolic complication characterised by visceral fat accumulation and altered fat distribution
US$ 21.51
US$ 20.74
US$ 20.09
US$ 20.27
US$ 24.54
US$ 29.07
US$ 28.49
